Certain dietary carbohydrates promote Listeria infection in a guinea pig model, while others prevent it

International Journal of Food Microbiology

Volumn 140, Issue 2-3, 2010, Pages 218-224

  Ebersbach, Tine ^a   Jørgensen, Julie Boeck ^a   Heegaard, Peter Michael ^a   Lahtinen, Sampo J ^b   Ouwehand, Arthur C ^b   Poulsen, Morten ^a   Frøkiær, Hanne ^c   Licht, Tine Rask ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Danisco Finland Oy   (Finland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Guinea pig; Listeria monocytogenes; Prebiotic; Prevention of infection

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; GLUCOSE; INSULIN; OLIGOSACCHARIDE; PECTIN; POLYDEXTROSE; UNCLASSIFIED DRUG; XYLOOLIGOSACCHARIDE; CARBOHYDRATE DIET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM DETECTION; CARBOHYDRATE ANALYSIS; CARBOHYDRATE DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GUINEA PIG; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; NONHUMAN; PH; QUANTITATIVE ANALYSIS; ADMINISTRATION AND DOSAGE; ANIMAL; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; GASTROINTESTINAL TRACT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY;

ANIMALS; DIETARY CARBOHYDRATES; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; GUINEA PIGS; HUMANS; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MALE; MIDDLE AGED; LISTERIOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); CAVIA; LISTERIA; LISTERIA MONOCYTOGENES; MALUS X DOMESTICA; POSIBACTERIA;

EID: 77953121852     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.03.030     Document Type: Article

References (38)

1. Andersen J.B., Roldgaard B.B., Lindner A.B., Christensen B.B., Licht T.R. Construction of a multiple fluorescence labelling system for use in co-invasion studies of Listeria monocytogenes. BMC Microbiology 2006, 6:86.
2. Andersen J.B., Roldgaard B.B., Christensen B.B., Licht T.R. Oxygen restriction increases the infective potential of Listeria monocytogenes in vitro in Caco-2 cells and in vivo in guinea pigs. BMC Microbiology 2007, 7:55.
3. Barrat E., Michel C., Poupeau G., vid-Sochard A., Rival M., Pagniez A., Champ M., Darmaun D. Supplementation with galactooligosaccharides and inulin increases bacterial translocation in artificially reared newborn rats. Pediatric Research 2008, 64:34-39.
4. Boesten R.J., de Vos W.M. Interactomics in the human intestine: lactobacilli and bifidobacteria make a difference. Journal of Clinical Gastroenterology 2008, 42(Suppl 3 Pt 2):S163-S167.
5. Bosscher D., Loo J.V., Franck A. Inulin and oligofructose as prebiotics in the prevention of intestinal infections and diseases. Nutrition Research Reviews 2006, 19:216-226.
6. Bovee-Oudenhoven I.M., Ten Bruggencate S.J., Lettink-Wissink M.L., Van der M.R. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats. Gut 2003, 52:1572-1578.
7. Buddington K.K., Donahoo J.B., Buddington R.K. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. Journal of Nutrition 2002, 132:472-477.
8. Drider D., Fimland G., Hechard Y., McMullen L.M., Prevost H. The continuing story of class IIa bacteriocins. Microbiology and Molecular Biology Reviews 2006, 70:564-582.
9. Fonnesbech B., Frokiaer H., Gram L., Jespersen C.M. Production and specificity of poly- and monoclonal antibodies raised against Shewanella putrefaciens. Journal of Applied Bacteriology 1993, 74:444-451.
10. Gibson G.R., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. Journal of Applied Bacteriology 1994, 77:412-420.
11. Gibson G.R., Beatty E.R., Wang X., Cummings J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995, 108:975-982.
12. Heegaard, P.M., Ebersbach, T., Licht, T.R., in preparation. Characterization of serum amyloid A as an acute phase protein in the guinea pig.
13. Hernot D.C., Boileau T.W., Bauer L.L., Middelbos I.S., Murphy M.R., Swanson K.S., Fahey G.C. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. Journal of Agricultural and Food Chemistry 2009, 57:1354-1361.
14. Kaplan H., Hutkins R.W. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Applied and Environmental Microbiology 2000, 66:2682-2684.
15. Larsen C.N., Norrung B., Sommer H.M., Jakobsen M. In vitro and in vivo invasiveness of different pulsed-field gel electrophoresis types of Listeria monocytogenes. Applied and Environmental Microbiology 2002, 68:5698-5703.
16. Lecuit M., Vandormael-Pournin S., Lefort J., Huerre M., Gounon P., Dupuy C., Babinet C., Cossart P. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 2001, 292:1722-1725.
17. Lomax A.R., Calder P.C. Prebiotics, immune function, infection and inflammation: a review of the evidence. British Journal of Nutrition 2008, 1-26.
18. Malle E., De Beer F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. European Journal of Clinical Investigation 1996, 26:427-435.
19. Mandalari G., Nueno P.C., Tuohy K., Gibson G.R., Bennett R.N., Waldron K.W., Bisignano G., Narbad A., Faulds C.B. In vitro evaluation of the prebiotic activity of a pectic oligosaccharide-rich extract enzymatically derived from bergamot peel. Applied Microbiology and Biotechnology 2007, 73:1173-1179.
20. McDonald T.L., Weber A., Smith J.W. A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein. Journal of Immunological Methods 1991, 144:149-155.
21. Orrhage K., Nord C.E. Bifidobacteria and lactobacilli in human health. Drugs Under Experimental and Clinical Research 2000, 26:95-111.
22. Palframan R.J., Gibson G.R., Rastall R.A. Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Current Issues in Intestinal Microbiology 2003, 4:71-75.
23. Pan X., Wu T., Zhang L., Cai L., Song Z. Influence of oligosaccharides on the growth and tolerance capacity of lactobacilli to simulated stress environment. Letters in Applied Microbiology 2009, 48:362-367.
24. Rhoades J., Manderson K., Wells A., Hotchkiss A.T., Gibson G.R., Formentin K., Beer M., Rastall R.A. Oligosaccharide-mediated inhibition of the adhesion of pathogenic Escherichia coli strains to human gut epithelial cells in vitro. Journal of Food Protection 2008, 71:2272-2277.
25. Roberfroid M. Prebiotics: the concept revisited. Journal of Nutrition 2007, 137:830S-837S.
26. Roberfroid M.B., Van Loo J.A., Gibson G.R. The bifidogenic nature of chicory inulin and its hydrolysis products. Journal of Nutrition 1998, 128:11-19.
27. Roldgaard B.B., Andersen J.B., Hansen T.B., Christensen B.B., Licht T.R. Comparison of three Listeria monocytogenes strains in a guinea-pig model simulating food-borne exposure. FEMS Microbiology Letters 2009, 291:88-94.
28. Seifert S., Watzl B. Inulin and oligofructose: review of experimental data on immune modulation. Journal of Nutrition 2007, 137:2563S-2567S.
29. Shoaf K., Mulvey G.L., Armstrong G.D., Hutkins R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infection and Immunity 2006, 74:6920-6928.
30. Smith M.A., Takeuchi K., Brackett R.E., McClure H.M., Raybourne R.B., Williams K.M., Babu U.S., Ware G.O., Broderson J.R., Doyle M.P. Nonhuman primate model for Listeria monocytogenes-induced stillbirths. Infection and Immunity 2003, 71:1574-1579.
31. Ten Bruggencate S.J.M., Bovee-Oudenhoven I.M.J., Lettink-Wissink M.L.G., Van der Meer R. Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella in rats. Journal of Nutrition 2003, 133:2313-2318.
32. Ten Bruggencate S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Katan M.B., Van der M.R. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium. Gut 2004, 53:530-535.
33. Ten Bruggencate S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Van der M.R. Dietary fructooligosaccharides increase intestinal permeability in rats. Journal of Nutrition 2005, 135:837-842.
34. Tuohy K.M., Kolida S., Lustenberger A.M., Gibson G.R. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides-a human volunteer study. British Journal of Nutrition 2001, 86:341-348.
35. Vazquez-Boland J.A., Kuhn M., Berche P., Chakraborty T., Dominguez-Bernal G., Goebel W., Gonzalez-Zorn B., Wehland J., Kreft J. Listeria pathogenesis and molecular virulence determinants. Clinical Microbiology Reviews 2001, 14:584-640.
36. Vernazza C.L., Gibson G.R., Rastall R.A. Carbohydrate preference, acid tolerance and bile tolerance in five strains of Bifidobacterium. Journal of Applied Microbiology 2006, 100:846-853.
37. Vos A.P., M'Rabet L., Stahl B., Boehm G., Garssen J. Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Critical Review in Immunology 2007, 27:97-140.
38. Wang X., Gibson G.R. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. Journal of Applied Bacteriology 1993, 75:373-380.